Company News
Jade Biosciences Shares Drop 6.5% on Offering
Jade Biosciences shares fell 6.5% in after‑hours trading after announcing an underwritten public offering of common stock or pre‑funded warrants.
The offering includes a 30‑day option for underwriters
